"It passes through our bodies, our cells and every living organism on the planet, yet we know surprisingly little about ...
Brain biomarkers were long hard to pin down. See how new Parkinson's and Alzheimer's biomarkers are changing that.
Heart and blood vessel diseases are common in people living with Alzheimer’s disease and Parkinson’s disease. Many of these ...
Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...
The Healthy @Reader's Digest on MSN
In a new study, dogs detected the second-most-common neurological disease—after Alzheimer’s—20 years ahead of doctors
It's a condition that's currently without an early diagnostic test, but there's a surprising—and furry—hint of hope for the ...
NKGen presented new clinical data on troculeucel’s potential in Alzheimer’s, Parkinson’s and frontotemporal dementia.
Learn how brain tissue donated to science after death gives clues about genetic changes in neurological disorders and how we ...
The outrage about Sir Ranulph Fiennes, and the idea that he has ‘disappeared’ from public view in his twilight ...
Learn how Earth's magnetic field may influence how we age and how its effects on mitochondria could reveal new therapies for ...
In mice whose brains accumulate clumps of tau protein, researchers found a way to protect nerve cells without clearing away those clumps. They interrupted an immune response directed from outside the ...
Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the ...
Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results